Gilead Sciences to start clinical trials of inhaled remdesivir for COVID-19
Monday, June 22, 2020 - 14:30
in Health & Medicine
Gilead Sciences plans to start clinical trials for an inhaled version of the antiviral remdesivir for the treatment of COVID-19, company officials said Monday.